Search our collection

View:

Filter search

Ampoules, 2, of dysentary vaccine, France, c. 1920

1918-1920

Human rabies vaccine

Rabies vaccine and distilled water

Human rabies vaccine

Human rabies vaccine,

Glass ampoule of dysentry vaccine, French

Human rabies vaccine

Two Wooden tubes

1830-1930

13 glass phials containing human rabies vaccine

Carton, for anti-catarrh vaccine, London, 1938

1938

20 glass phials containing human rabies vccine, pr

Ampoule of dysentery vaccine, French, c. 1916

1914-1917

Laboratory sample of peptides S7

1987

Ampoule of dysentery vaccine, French, c. 1916

1915-1917

Diphtheria, tetanus and pertussis vaccine

Box containing a single disposable syringe prefilled with 1ml of Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993

Disposable syringe of Engerix B Vaccine, boxed

1993

One of two glass vials, each containing 1ml (10 doses) of Poliomyelitis vaccine for oral administration, as used in the UNICEF/WHO Extended Programme on Immunisation (EPI), manufactured by Pasteur Merieux, Lyon, France, 1994

Poliomyelitis vaccine

1994

One of four glass vials, containing a small amount of freeze-dried `Rouvax' vaccine, manufactured by Pasteur Merieux, Lyon, France, 1994

Freeze-dried Rouvax vaccine

1994

Phial, glass, containing human rabies vaccine, for pre-exposure immunisation, in cardboard box, with instructions, by Connaught Research Laboratories of Toronto, Canada, 1971, tissue culture origin

Glass phial containing human rabies vaccine

1971

Ampoule of tetanus antitoxin, with instructions, in original carton, by Burroughs Wellcome and Co., English, 1954

Ampoule of tetanus antitoxin with instructions

1852

Box containing ampoules of DTP "Trivax" vaccine, for vaccination of infants against Diphtheria, Pertussis (Whooping Cough) and Poliomyelitis, manufactured by Wellcome Plc, England, 1994

Box containing ampoules of DTP "Trivax" vaccine

1994

Small drug jar containing lanoline vaccine, 1892

Small drug jar containing lanoline vaccine, 1892

1892

One of four glass vials, containing 5ml of sterile water diluent, to provide 10 doses of vaccine per vial on mixing, for protection against Measles as part of the UNICEF/WHO Extended Programme on Immunisation (EPI), manufactured by Pasteur Merieux, Lyon, France, 1994

Sterile water diluent

1994

Two glass vials, each containing 1ml (10 doses) of Poliomyelitis vaccine for oral administration, as used in the UNICEF/WHO Extended Programme on Immunisation (EPI), manufactured by Pasteur Merieux, Lyon, France, 1994

Two glass vials

Four glass vials, two containing a small amount of freeze-dried `Rouvax' vaccine, and two containing 5ml of sterile water diluent, to provide 10 doses of vaccine per vial on mixing, for protection against Measles as part of the UNICEF/WHO Extended Programme on Immunisation (EPI), manufactured by Pasteur Merieux, Lyon, France, 1994

Four glass vials

Two Wooden tubes, cartons for tubes of calf lymph and a priced advertisement for calf lymph, by the Animal Vaccine Laboratory, Paris, France, 1830-1930. Supplied by Roberts and Co., 76 New Bond Street, London, England.

Two Wooden tubes for tubes of calf lymph and a priced advertisement

1830-1930

2 packs of `Mumpsvax' mumps virus vaccine (live attenuated) Jeryl Lynn Strain, each containing a one-dose vial, 0.5ml, by Thomas Morson Pharmaceuticals, Hertford Road, Hoddesdon, Hertfordshire, 1987

Two packets of "Mumpsvax" vaccine

1987

Six glass ampoules containing freeze-dried B.C.G. vaccine for intradermal injection, for hydration with sodium chloride to provide ten doses, provided by UNICEF and manufactured by Evans Medical Ltd, Langhurst, Horsham, England, c. 1980-1985

Freeze-dried BCG vaccine

1980-1985

3 hypodermic syringes containing course of pollinex hay fever vaccine in box, prepared by Bencard, Middlesex, 1980-1981

Pollinex hay fever vaccine

1980-1981

Collection of material relating to the Vaccine HibTITER, primarily used for the protection of infants against Hib (Haemophilus Influenzae type b) Meningitis, and the accompanying LIVE (Lederle Initiative in Vaccine Education) health education programme, including a demonstration pack of empty single dose HibTITER vials, educational video, LIVE information pack, product handbook, `Question and Answer' leaflets and other promotional material, by Lederle-Praxis, Gosport, England, 1992-1993

Vaccine HibTITER information

1992-1993

One of two glass vials, each containing 10ml (20 doses) of `Tetavax' vaccine for subcutaneous or intramuscular injection to provide protection against Tetanus, as part of the UNICEF/WHO Extended Programme on Immunisation (EPI), expiry date 06/96, manufactured by Pasteur Merieux, Lyon, France, 1994

One of two glass vials

1994

Sample of synthetic peptide vaccine SPf66, developed by Dr Patarroyo and collaborators as a synthetic vaccine for malaria, Bogota, Colombia, with placebo, as used in the Phase III randomised, double-blind, placebo controlled trial at La Tola, Colombia, 1992. (The Lancet, 20 March 1993)

Sample of synthetic peptide vaccine SPf66

1992